miscsubjectsAI governance
Evidence review

Tesamorelin for Muscle Loss: Human Evidence on Lean Mass, Muscle Density, and the GH Axis

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `tesamorelin-muscle-loss`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/tesamorelin-muscle-loss

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-muscle-loss/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
This is the largest single-authored interlocked logical structure published in the open that I am aware of: thousands of objects — a theory of everything, a theory of AI, and a replicated decision framework — where every piece fits every other piece, and every claim carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. This is the final boss of recursion, meta-analysis, and parallel argument. Come at a node.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why Tesamorelin might help you

  1. Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Tesamorelin → GH axis / visceral fat

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 3
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 2
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Quantified confidence (this ledger): 0.45 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV (source s1)

Secondary analysis of two RCTs; CT-based muscle metrics in responders.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

A meta-analysis of randomized controlled trials (source s2)

Pooled body composition outcomes from tesamorelin trials in HIV lipodystrophy.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Tesamorelin as an Adjunct to Exercise for Improving Physical Function and Muscle Health in Adults With HIV (source s3)

Active trial combining tesamorelin with exercise.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Tesamorelin Belly Fat Reduction — Reddit, r/USPeptides (source s4)

User discussion on muscle preservation.

Starting Tesamorelin — Reddit, r/Biohackers (source s5)

Self-reported body composition changes.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Muscle loss / sarcopenia · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 5 sources · swipe →chain 500a99f3722c · verify chain · provenance
Evidence ledger 4 · tier-ranked · API
human
In a secondary analysis of randomized trials, tesamorelin responders (visceral fat loss ≥8%) showed greater increases in trunk muscle density (1.56–4.86 HU) and lean muscle area (0.64–1.08 cm²) vs placebo after 26 weeks.
sources: s1
humanlow confidence
Meta-analysis of tesamorelin trials reported a mean lean body mass increase of 1.42 kg alongside visceral fat reduction.
sources: s2
humanlow confidence
An ongoing clinical trial (NCT06554717) is evaluating tesamorelin plus exercise for physical function and muscle health in adults with HIV.
sources: s3
anecdotallow confidence
Reddit users report lean mass preservation or modest gains alongside visceral fat loss when using tesamorelin in calorie deficits, often with improved recovery.
sources: s4, s5
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-29 23:19
Tesamorelin for Muscle Loss: Human Evidence on Lean Mass, Muscle Density, and the GH Axis · 4 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Tesamorelin for Muscle Loss
Slug: tesamorelin-muscle-loss
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"tesamorelin","name":"Tesamorelin"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative
it output
{
  "slug": "tesamorelin-muscle-loss",
  "title": "Tesamorelin for Muscle Loss: Human Evidence on Lean Mass, Muscle Density, and the GH Axis",
  "body": "## What's breaking down\nMuscle loss, or sarcopenia-like decline, often stems from reduced growth hormone (GH) signaling with age or illness. This lowers IGF-1, slowing protein synthesis while catabolic processes continue. Visceral fat accumulation adds mechanical and inflammatory stress that can further impair muscle quality. In HIV-related lipodystrophy, excess abdominal fat pairs with muscle fat infiltration and reduced lean area. Repair pathways lag behind breakdown when GH pulses weaken. Tesamorelin is discussed here because studies examine its effect on the GH axis and downstream tissue changes rather than symptom masking.\n\n## Why Tesamorelin might help you\nIf your muscle loss involves low GH/IGF-1 activity or excess visceral fat, the logic chain runs like this. Tesamorelin stimulates the pituitary to release endogenous GH in a more physiologic pattern. That raises circulating IGF-1. Higher IGF-1 supports protein synthesis in muscle tissue. In people who respond with visceral fat reduction, CT scans showed measurable gains in trunk muscle density and lean muscle area over 26 weeks. Therefore, if visceral fat or poor muscle quality is part of your profile, the compound is studied for its potential to shift the balance 
d531986ced9cab26
Machine verification: /api/articles/tesamorelin-muscle-loss/contributions
Ask this article · 8 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "In a secondary analysis of randomized trials, tesamorelin responders (visceral fat loss ≥8%) showed greater increases in trunk muscle densit…"?
ask tesamorelin-muscle-loss claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "Meta-analysis of tesamorelin trials reported a mean lean body mass increase of 1.42 kg alongside visceral fat reduction."?
ask tesamorelin-muscle-loss claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "An ongoing clinical trial (NCT06554717) is evaluating tesamorelin plus exercise for physical function and muscle health in adults with HIV."?
ask tesamorelin-muscle-loss claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users report lean mass preservation or modest gains alongside visceral fat loss when using tesamorelin in calorie deficits, often wit…"?
ask tesamorelin-muscle-loss claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User discussion on muscle preservation."
ask tesamorelin-muscle-loss source s4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Self-reported body composition changes."
ask tesamorelin-muscle-loss source s5 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about Tesamorelin for Muscle Loss: Human Evidence on Lean Mass, Muscle Density, and the GH Axis — and what would you need me to tell you first?
ask tesamorelin-muscle-loss condition gaps · paste includes §SELF
What good and bad outcomes are documented for Tesamorelin for Muscle Loss: Human Evidence on Lean Mass, Muscle Density, and the GH Axis (studies vs anecdotes)?
ask tesamorelin-muscle-loss good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →